Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Edwankar

Chitra R. Edwankar, Milwaukee, WI US

Patent application numberDescriptionPublished
20100261711SELECTIVE ANTICONVULSANT AGENTS AND THEIR USES - In preferred embodiments, the present invention provides methods of treatment and pharmaceutical compositions for the suppression, alleviation and prevention of seizures. The preferred embodiments of the present invention further relate to methods of treatment and pharmaceutical compositions using benzodiazepine derivatives that provide suppression, alleviation and prevention of seizures with reduced sedative and ataxic side effects.10-14-2010

Rahul Edwankar, Milwaukee, WI US

Patent application numberDescriptionPublished
20100317619Selective Agents for Pain Suppression - In preferred embodiments, the present invention provides methods of treatment and pharmaceutical compositions for the suppression, alleviation and prevention of the often chronic, severe and debilitating pain that can accompany inflammatory diseases and neuropathic insults, pain that is often unresponsive to conventional analgesic treatment. The preferred embodiments of the present invention further relate to methods of treatment and pharmaceutical compositions using benzodiazepine derivatives that provide suppression, alleviation and prevention of neuropathic pain, migraine-related pain and inflammatory pain with reduced sedative and ataxic side effects.12-16-2010

Rahul V. Edwankar, Milwaukee, WI US

Patent application numberDescriptionPublished
20100261711SELECTIVE ANTICONVULSANT AGENTS AND THEIR USES - In preferred embodiments, the present invention provides methods of treatment and pharmaceutical compositions for the suppression, alleviation and prevention of seizures. The preferred embodiments of the present invention further relate to methods of treatment and pharmaceutical compositions using benzodiazepine derivatives that provide suppression, alleviation and prevention of seizures with reduced sedative and ataxic side effects.10-14-2010